Advertisement

Intra-articular injection of tranexamic acid reduce blood loss in cemented total knee arthroplasty

  • G. DigasEmail author
  • I. Koutsogiannis
  • G. Meletiadis
  • E. Antonopoulou
  • V. Karamoulas
  • Ch. Bikos
Original Article • KNEE - ARTHROPLASTY

Abstract

The purpose of this study was to compare the efficacy of intravenous and topical tranexamic acid (TXA) versus control group for reduction in blood loss following primary total knee arthroplasty (TKA). A total of 90 patients were prospectively allocated to each of three groups (control, intravenous IV and intra-articular) and underwent unilateral total knee arthroplasty. In the IV group, patients received one dose of TXA of 15 mg/kg before deflation of the tourniquet, while in the intra-articular group patients received 2 g TXA via the drain retrogradely after closure of the wound. The mean drained blood loss in control, IV and intra-articular groups was 415 ± 24, 192 ± 21 and 121 ± 17 ml, respectively. About 43 % (control), 23 % (IV) and 17 % (intra-articular) of each group required transfusion, and the mean transfusion was 338, 168 and 79 ml, respectively. Preoperative hemoglobin values decreased at 24 h by 2.80 ± 0.14, 2.24 ± 0.17 and 2.26 ± 0.18 mg/dl, respectively. TXA reduced blood loss and transfusion requirement. Compared with one-dose intravenous administration, intra-articular administration of TXA seems to be more effective in terms of reducing drained blood loss and transfusion frequency. We recommend administration of topical TXA in primary TKA in healthy patients to decrease perioperative blood loss.

Keywords

Total knee arthroplasty Tranexamic acid Blood loss Transfusion 

Notes

Conflict of interest

None.

References

  1. 1.
    Risberg B (1985) The response of the fibrinolytic system in trauma. Acta Chir Scand Suppl 522:245–271PubMedGoogle Scholar
  2. 2.
    Benoni G, Carlsson A, Petersson C, Fredin H (1995) Does tranexamic acid reduces blood loss after total knee arthroplasty? Am J Knee Surg 8:88–92PubMedGoogle Scholar
  3. 3.
    Klenerman L, Chakrabarti R, Mackie I, Brozovic M, Stirling Y (1977) Changes in the hemostatic system after application of a tourniquet. The Lancet 1(8019):970–972Google Scholar
  4. 4.
    Petaja J, Myllynen P, Myllyla G, Vahtera E (1987) Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand 153:647–651PubMedGoogle Scholar
  5. 5.
    Cardone D, Klein AA (2009) Perioperative blood conservation. Eur J Anaesthesiol 26:722–729CrossRefPubMedGoogle Scholar
  6. 6.
    Kumar A (2009) Perioperative management of anemia: limits of blood transfusion and alternatives to it. Clevel Clin J Med 76(4):112–118CrossRefGoogle Scholar
  7. 7.
    Claeys MA, Vermeersch N, Haentjens P (2007) Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 107:397–401PubMedGoogle Scholar
  8. 8.
    Lemaire R (2008) Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 90:1128–1136CrossRefPubMedGoogle Scholar
  9. 9.
    Cid J, Lozano M (2005) Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 45:1302–1307CrossRefPubMedGoogle Scholar
  10. 10.
    Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W (2009) Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopaedic surgery: a systematic review of randomized trials. Thromb Res 123:687–696CrossRefPubMedGoogle Scholar
  11. 11.
    Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S (2006) Do antifibrinolytics reduce allogeneic blood transfusion in orthopaedic surgery? Anesthesiology 105:1034–1046CrossRefPubMedGoogle Scholar
  12. 12.
    Graham ID, Alvarez G, Tetroe J, McAuley L, Laupacis A (2002) Factors influencing the adoption of blood alternatives to minimize allogeneic transfusion: the perspective of eight Ontario hospitals. Can J Surg 45:132–140PubMedCentralPubMedGoogle Scholar
  13. 13.
    Mannucci PM (1998) Hemostatic drugs. N Engl J Med 339:245–253CrossRefPubMedGoogle Scholar
  14. 14.
    Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92(15):2503–2513CrossRefPubMedGoogle Scholar
  15. 15.
    Gross JB (1983) Estimating allowable blood loss: corrected for dilution. Anaesthesiology 58:277–280CrossRefGoogle Scholar
  16. 16.
    Liu X, Zhang X, Chen Y, Wang Q, Jiang Y, Zeng B (2011) Hidden blood loss after total hip arthroplasty. J Arthroplasty 26(7):1100–1105CrossRefPubMedGoogle Scholar
  17. 17.
    Nadler SB, Hidalgo JU, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51(2):224–232PubMedGoogle Scholar
  18. 18.
    Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM (2011) Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 93:1577–1585CrossRefPubMedGoogle Scholar
  19. 19.
    Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 78:434–440PubMedGoogle Scholar
  20. 20.
    Camarasa MA, Ollé G, Serra-Prat M, Martín A, Sánchez M, Ricós P, Pérez A, Opisso L (2006) Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 96:576–582CrossRefPubMedGoogle Scholar
  21. 21.
    Dahuja A, Dahuja G, Jaswal V, Sandhu K (2014) A prospective study on role of tranexamic acid in reducing postoperative blood loss in total knee arthroplasty and its effect on coagulation profile. J Arthroplasty 29:733–735CrossRefPubMedGoogle Scholar
  22. 22.
    Hiippala S, Strid L, Wennerstrand M, Arvela V, Mäntylä S, Ylinen J, Niemelä H (1995) Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 74:534–537CrossRefPubMedGoogle Scholar
  23. 23.
    Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemelä HM, Mäntylä SK, Kuisma RP, Ylinen JE (1997) Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 84:839–844PubMedGoogle Scholar
  24. 24.
    Jansen AJ, Andreica S, Claeys M, D’Haese J, Camu F, Jochmans K (1999) Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 83:596–601CrossRefPubMedGoogle Scholar
  25. 25.
    Sarzaeem MM, Razi M, Kazemian G, Moghaddam ME, Rasi AM, Karimi M (2014) Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. J Arthroplasty 29:1521–1524CrossRefPubMedGoogle Scholar
  26. 26.
    Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 83:702–705CrossRefPubMedGoogle Scholar
  27. 27.
    Yang ZG, Chen WP, Wu LD (2012) Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 94:1153–1159CrossRefPubMedGoogle Scholar
  28. 28.
    Zhang H, Chen J, Chen F, Que W (2012) The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 20:1742–1752CrossRefPubMedGoogle Scholar
  29. 29.
    Seo JG, Moon YW, Park SH, Kim SM, Ko KR (2013) The comparative efficacies of intra-articular and iv tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 21(8):1869–1874CrossRefPubMedGoogle Scholar
  30. 30.
    Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP (2013) Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am 95(21):1961–1968CrossRefPubMedGoogle Scholar
  31. 31.
    Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW (2013) A prospective doubleblind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 28(8):78–82CrossRefPubMedGoogle Scholar
  32. 32.
    Ishida K, Tsumura N, Kitagawa A, Hamamura S, Fukuda K, Dogaki Y, Kubo S, Matsumoto T, Matsushita T, Chin T, Iguchi T, Kurosaka M, Kuroda R (2011) Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 35(11):1639–1645PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Roy SP, Tanki UF, Dutta A, Jain SK, Nagi ON (2012) Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 20(12):2494–2501CrossRefPubMedGoogle Scholar
  34. 34.
    Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV (2013) Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee 20(5):300–309CrossRefPubMedGoogle Scholar
  35. 35.
    Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S (2013) An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 28(8):74–77CrossRefPubMedGoogle Scholar
  36. 36.
    Craik JD, Ei Shafie SA, Kidd AG, Twyman RS (2014) Can local administration of tranexamic acid during total knee arthroplasty reduce blood loss and transfusion requirements in the absence of surgical drains? Eur J Orthop Surg Traumatol 24(3):379–384CrossRefPubMedGoogle Scholar
  37. 37.
    Gilbody J, Dhotar HS, Perruccio AV, Davey JR (2014) Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty 29(4):681–684CrossRefPubMedGoogle Scholar
  38. 38.
    Konig G, Hamlin BR, Waters JH (2013) Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty 28(9):1473–1476CrossRefPubMedGoogle Scholar
  39. 39.
    Wind TC, Barfield WR, Moskal JT (2013) The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J Arthroplasty 28(7):1080–1083CrossRefPubMedGoogle Scholar
  40. 40.
    Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR (2012) Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 470:2605–2612PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Soni A, Saini R, Gulati A, Paul R, Bhatty S, Rajoli SR (2014) Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. J Arthroplasty 29:1525–1527CrossRefPubMedGoogle Scholar
  42. 42.
    Zhang W, Li N, Chen S, Tan Y, Al-Aidaros M, Chen L (2014) The effects of a tourniquet used in total knee arthroplasty: a meta-analysis. J Orthop Surg Res 9:13. doi: 10.1186/1749-799X-9-13 PubMedCentralCrossRefPubMedGoogle Scholar
  43. 43.
    Good L, Peterson E, Lisander B (2003) Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 90:596–599CrossRefPubMedGoogle Scholar
  44. 44.
    Parvizi J, Pawasarat IM, Azzam KA, Joshi A, Hansen EN, Bozic KJ (2010) Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplast 25:103–107CrossRefGoogle Scholar

Copyright information

© Springer-Verlag France 2015

Authors and Affiliations

  1. 1.Orthopaedic departmentGeneral Hospital XanthiXanthiGreece

Personalised recommendations